{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35546010", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "05", "Day": "11"}], "ELocationID": ["e2022060", "10.23750/abm.v93i2.12291"], "Journal": {"ISSN": "2531-6745", "JournalIssue": {"Volume": "93", "Issue": "2", "PubDate": {"Year": "2022", "Month": "May", "Day": "11"}}, "Title": "Acta bio-medica : Atenei Parmensis", "ISOAbbreviation": "Acta Biomed"}, "ArticleTitle": "Ozone improved the wound healing in type 2 diabetics via down-regulation of IL- 8, 10 and induction of FGFR expression.", "Pagination": {"StartPage": "e2022060", "MedlinePgn": "e2022060"}, "Abstract": {"AbstractText": ["We aimed to investigate the effect of ozonated autohaemotherapy (OA) on the wound\u00a0 healing, serum values of interleukin (IL) - 6, 8, 10, tumor necrosis factor-alpha (TNF-\u03b1), basic fibroblast growth factor (bFGF) and local expression of fibroblast growth factor receptors (FGFR) in type 2 diabetics with the acute soft-tissue infections.", "Patients in the first cohort (n-30) received a basic comprehensive treatment (BCT-group), and the second (n=28) also received OA (OA-group). Blood samples for ELISA and tissue specimens for the immunohistochemical examinations were collected at admission (day 0) and at the 9th day of inpatient treatment.", "The additional using of OA has accelerated the timing of a single and the complete wound granulation and the timing to marginal epithelization, compared with the results of the standard treatment. The use of OA has significantly reduced the production of IL-8, 10 at 9th day. OA-group patients were characterized by consistently high levels of bFGF production in contrast to the BCT-group, where the decreasing in the serum bFGF level was observed. The maximum number of bFGFR - immunopositive labels was observed in OA-group out to 9th day (319,45 (249,90-348,43) versus\u00a0baseline 192,65 (171,93-207,72), versus BCT-group 123,30 (105,23- 141,10),\u00a0 p<0,001).", "Application of OA in the complex treatment of the acute soft-tissue infections in diabetics makes it possible to achieve the significant reductions in the duration of the wound inflammation and regeneration phases by eliminating of overproduction of IL- 8, 10 and induction of expression of bFGF and its receptors."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery named after Professor M. I. Gulman, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation. teplyakova-olga@ya.ru."}], "LastName": "Teplyakova", "ForeName": "Olga", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery named after Professor M. I. Gulman, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation. yuvinnik@yandex.ru."}], "LastName": "Vinnik", "ForeName": "Yurii", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery named after Professor M. I. Gulman, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation; Center for collective use \u00abMolecular & cell technologies\u00bb, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation . annushkadoc@mail.ru."}], "LastName": "Drobushevskaya", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Chemistry with the Course of Medical, Pharmaceutical and Toxicological Chemistry, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation; Research Institute of Molecular Medicine and Pathobiochemistry, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation; Center for collective use \u00abMolecular & cell technologies\u00bb, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation. malinovskaya-na@mail.ru."}], "LastName": "Malinovskaya", "ForeName": "Natalia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathological Anatomy named after Professor P. G. Podzolkov, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation; Department of Pathological Anatomy, Clinical hospital \u00abRZD-Medicine\u00bb city Krasnoyarsk, Krasnoyarsk, Russian Federation. krasak.07@mail.ru."}], "LastName": "Kirichenko", "ForeName": "Andrey", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery named after Professor M. I. Gulman, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation. ponedela.dasha12@mail.ru."}], "LastName": "Ponedelnik", "ForeName": "Darya", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Acta Biomed", "NlmUniqueID": "101295064", "ISSNLinking": "0392-4203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Receptors, Fibroblast Growth Factor"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["complications"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Down-Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Receptors, Fibroblast Growth Factor"}, {"QualifierName": [], "DescriptorName": "Wound Healing"}], "CoiStatement": "Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ch\u00e1vez-Reyes J, Esc\u00e1rcega-Gonz\u00e1lez CE, Chavira-Su\u00e1rez E, et al. Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia. Front Public Health. 2021;9:559595. doi: 10.3389/fpubh.2021.559595.", "ArticleIdList": ["PMC7921169", "33665182"]}, {"Citation": "Suaya JA, Eisenberg DF, Fang C, Miller LG. Skin and soft tissue infections and associated complications among commercially insured patients aged 0\u201364 years with and without diabetes in the U.S. PLoS One. 2013;8(4):e60057. doi: 10.1371/journal.pone.0060057.", "ArticleIdList": ["PMC3622669", "23593162"]}, {"Citation": "Must\u0103\u0163ea P, Bug\u0103 C, Doran H, et al. Soft tissue infections in diabetic patients. Chirurgia (Bucur) 2018;113(5):651\u201367.", "ArticleIdList": ["30383992"]}, {"Citation": "Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23(1):3\u201313.", "ArticleIdList": ["16960917"]}, {"Citation": "Demidova-Rice TN, Hamblin MR, Herman IM. Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. Adv Skin Wound Care. 2012;25(7):304\u201314.", "ArticleIdList": ["PMC3428147", "22713781"]}, {"Citation": "Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8(3):235\u201353.", "ArticleIdList": ["PMC3684054", "19247306"]}, {"Citation": "Freiin von H\u00f6vel F, Kefalakes E, Grothe C. What can we learn from FGF-2 isoform specific mouse mutants? Differential insights into FGF-2 physiology in vivo. Int J Mol Sci. 2021;22(1):390. doi: 10.3390/ijms22010390.", "ArticleIdList": ["PMC7795026", "33396566"]}, {"Citation": "Shi HX, Lin C, Lin BB, et al. The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo. PLoS One. 2013;8(4):e59966. doi: 10.1371/journal.pone.0059966.", "ArticleIdList": ["PMC3615060", "23565178"]}, {"Citation": "Komi-Kuramochi A, Kawano M, Oda Y, et al. Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. J Endocrinol. 2005;186(2):273\u201389.", "ArticleIdList": ["16079254"]}, {"Citation": "Meyer M, M\u00fcller AK, Yang J, et al. FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin. J Cell Sci. 2012;125(23):5690\u2013701.", "ArticleIdList": ["PMC3575704", "22992463"]}, {"Citation": "Shah JM, Omar E, Pai DR, Sood S. Cellular events and biomarkers of wound healing. Indian J Plast Surg. 2012;45(2):220\u20138.", "ArticleIdList": ["PMC3495371", "23162220"]}, {"Citation": "Marti-Carvajal AJ, Gluud C, Nicola S, et al. Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2015;10:CD008548. doi:10.1002/14651858.CD008548.pub2.", "ArticleIdList": ["PMC8665376", "26509249"]}, {"Citation": "Fernandez-Montequin JI, Betancourt BY, Leyva-Gonzalez G, et al. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: Treatment up to complete wound closure. Int Wound J. 2009;6(1):67\u201372.", "ArticleIdList": ["PMC7951202", "19291119"]}, {"Citation": "Loot MA, Kenter SB, Au FL, et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol. 2002;81(3):153\u201360.", "ArticleIdList": ["11998867"]}, {"Citation": "Cowin AJ, Hatzirodos N, Holding CA, et al. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers. J Invest Dermatol. 2001;117(5):1282\u20139.", "ArticleIdList": ["11710945"]}, {"Citation": "Costantini S, Capone F, Guerriero E, et al. Cytokinome profile of patients with type 2 diabetes and / or chronic hepatitis C infection. PLoS ONE. 2012;7(6):e39486.", "ArticleIdList": ["PMC3379982", "22745767"]}, {"Citation": "Berlanga-Acosta J, Schultz GS, L\u00f3pez-Mola E, Guillen-Nieto G, Garc\u00eda-Siverio M, Herrera-Mart\u00ednez L. Glucose toxic e\ufb00ects on granulation tissue productive cells: the diabetics\u2019 impaired healing. Biomed Res Int. 2013:e256043.", "ArticleIdList": ["PMC3591209", "23484099"]}, {"Citation": "Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular modeling, and wound healing. Int J Vasc Med. 2012:e918267.", "ArticleIdList": ["PMC3348526", "22611498"]}, {"Citation": "Sun DP, Yeh CH, So E, et al. Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression. Cytokine. 2013;62(3):360\u20138.", "ArticleIdList": ["23582717"]}, {"Citation": "Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, Marston WA. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg. 2009;49(4):1013\u201320.", "ArticleIdList": ["PMC4710545", "19341889"]}, {"Citation": "Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen. 2000;8(1):13\u201325.", "ArticleIdList": ["10760211"]}, {"Citation": "Jiang L, Dai Y, Cui F, et al. Expression of cytokines, growth factors and apoptosis-related signal molecules in chronic pressure ulcer wounds healing. Spinal Cord. 2014;52(2):145\u201351.", "ArticleIdList": ["24296807"]}, {"Citation": "Bocci V, Zanardi L, Huijberts MSP, Travagli V. Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2011;5(1):45\u20139.", "ArticleIdList": ["22814842"]}, {"Citation": "Gracer RI, Bocci V. Can the combination of localized proliferative therapy\u201d with minor ozonated autohaemotherapy\u201d restore the natural healing process? Med Hypotheses. 2005;65(4):752\u20139.", "ArticleIdList": ["15951134"]}, {"Citation": "Re L, Mawsouf MN, Men\u00e9ndez S, Le\u00f3n OS, S\u00e1nchez GM, Hern\u00e1ndez F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Archives of Medical Research. 2008;39(1):17\u201326.", "ArticleIdList": ["18067991"]}, {"Citation": "Wainstein J, Feldbrin Z, Boaz M, Harman-Boehm I. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Diabetes Technol Ther. 2011;13(12):1255\u201360.", "ArticleIdList": ["21751891"]}, {"Citation": "Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7(3):212\u20139.", "ArticleIdList": ["PMC5674660", "29152215"]}, {"Citation": "Di Mauro R, Cantarella G, Bernardini R, et al. The biochemical and pharmacological properties of ozone: the smell of protection in acute and chronic diseases. Int J Mol Sci. 2019;20(3):634.", "ArticleIdList": ["PMC6387239", "30717203"]}, {"Citation": "Zeng J, Lu J. Mechanisms of action involved in ozone-therapy in skin diseases. Int Immunopharmacol. 2018;56:235\u201341.", "ArticleIdList": ["29414657"]}, {"Citation": "Fuccio C, Luongo C, Capodanno P, et al. A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. Eur J Pharmacol. 2009;603(1-3):42\u20139.", "ArticleIdList": ["19100257"]}, {"Citation": "Sahin H, Simsek T, Turkon H, et al. The acute effects of preoperative ozone theraphy on surgical wound healing. Acta Cir Bras. 2016;31(7):472\u20138.", "ArticleIdList": ["27487282"]}, {"Citation": "Oguz E, Ekinci S, Eroglu M, et al. Evaluation and comparison of the effects of hyperbaric oxygen and ozonized oxygen as adjuvant treatments in an experimental osteomyelitis model. J Surg Res. 2011;171(1):61\u20138.", "ArticleIdList": ["21920551"]}, {"Citation": "Vaillant JD, Fraga A, D\u00edaz MT, et al. Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG / PS-induced arthritis in rats. Eur J Pharmacol. 2013;714(1-3):318\u201324.", "ArticleIdList": ["23911887"]}, {"Citation": "Simonetti V, Quagliariello V, Franzini M, Iaffaioli RV, Maurea N, Valdenassi L. Ozone exerts cytoprotective and anti-inflammatory effects in cardiomyocytes and skin fibroblasts after incubation with doxorubicin. Evid Based Complement Alternat Med. 2019:2169103. doi: 10.1155/2019/2169103.", "ArticleIdList": ["PMC6885772", "31827546"]}, {"Citation": "Deng L, Meng W, Li D, Qiu D, Wang S, Liu H. The effect of ozone on hypoxia, hemolysis and morphological change of blood from patients with aortic dissection (AD): a preliminary in vitro experiment of ozonated autohemotherapy for treating AD. Am J Transl Res. 2018;10(6):1829\u20131840.", "ArticleIdList": ["PMC6038082", "30018723"]}, {"Citation": "Ameli J, Banki A, Khorvash F, Simonetti V, Jafari NJ, Izadi M. Mechanisms of pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy: a systematic review. Acta Biomed. 2019;90(3):213\u20137.", "ArticleIdList": ["PMC7233748", "31580307"]}, {"Citation": "Borrelli E, Diadori A, Zalaffi A, Bocci V. Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study. Int J Ophthalmol. 2012;5(6):708\u201313.", "ArticleIdList": ["PMC3530813", "23275905"]}, {"Citation": "Moreno-Fern\u00e1ndez A, Mac\u00edas-Garc\u00eda L, Valverde-Moreno R, et al. Autohemotherapy with ozone as a possible effective treatment for fibromyalgia. Acta Reumatol Port. 2019;44(3):244\u20139.", "ArticleIdList": ["31575841"]}, {"Citation": "Nataraj M, Maiya AG, Karkada G, et al. Application of topical oxygen therapy in healing dynamics of diabetic foot ulcers - a systematic review. Rev Diabet Stud. 2019;15:74\u201382.", "ArticleIdList": ["PMC6946089", "31904759"]}, {"Citation": "Wen Q, Chen Q. An overview of ozone therapy for treating foot ulcers in patients with diabetes. Am J Med Sci. 2020;360(2):112\u20139.", "ArticleIdList": ["32534720"]}, {"Citation": "Juchniewicz H, Lubkowska A. Oxygen-ozone (O2-O3) therapy in peripheral arterial disease (PAD): a review study. Ther Clin Risk Manag. 2020;16:579\u201394.", "ArticleIdList": ["PMC7334138", "32636631"]}, {"Citation": "Kushmakov R, Gandhi J, Seyam O, et al. Ozone therapy for diabetic foot. Med Gas Res. 2018;8(3):111\u201315.", "ArticleIdList": ["PMC6178637", "30319766"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Al-Dalain SM, Men\u00e9ndez S, et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;523(1-3):151\u201361.", "ArticleIdList": ["16198334"]}, {"Citation": "Zhang J, Guan M, Xie C, Luo X, Zhang Q, Xue Y. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxid Med Cell Longev. 2014:273475. doi: 10.1155/2014/273475.", "ArticleIdList": ["PMC4096389", "25089169"]}, {"Citation": "Hassanien M, Rashad S, Mohamed N, Elawamy A, Ghaly MS. Non-invasive oxygen-ozone therapy in treating digital ulcers of patients with systemic sclerosis. Acta Reumatol Port. 2018;43(3):210\u20136.", "ArticleIdList": ["30414369"]}, {"Citation": "Xiao W, Tang H, Wu M, et al. Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K/Akt/mTOR signaling pathway. Biosci Rep. 2017;37(6):BSR20170658. doi: 10.1042/BSR20170658.", "ArticleIdList": ["PMC5678031", "28864782"]}, {"Citation": "Pchepiorka R, Moreira MS, Lascane NADS, et al. Effect of ozone therapy on wound healing in the buccal mucosa of rats. Arch Oral Biol. 2020;119:104889. doi: 10.1016/j.archoralbio.2020.104889.", "ArticleIdList": ["32911119"]}, {"Citation": "Taqwim Hidayat A, Thohar Arifin M, Nur M, Muniroh M, Susilaningsih N. Ozonated aloe vera oil effective increased the number of fibroblasts and collagen thickening in the healing response of full-thickness skin defects. Int J Inflam 2021. 2021:6654343. doi: 10.1155/2021/6654343.", "ArticleIdList": ["PMC7886587", "33628417"]}, {"Citation": "Vinnik IuS, Salmina AB, Tepliakova OV, et al. The results of combined ozone therapy using in complex treatment of soft tissues infections in patients with diabetes mellitus type II. Khirurgiia (Mosk) 2015;2:63\u20139.", "ArticleIdList": ["26031822"]}, {"Citation": "Leal EC, Carvalho E, Tellechea A, et al. Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype. Am J Pathol. 2015;185(6):1638\u201348.", "ArticleIdList": ["PMC4450333", "25871534"]}, {"Citation": "Dasu MR, Martin SJ. Toll-like receptor expression and signaling in human diabetic wounds. World J Diabetes. 2014;5(2):219\u201323.", "ArticleIdList": ["PMC3990321", "24748934"]}, {"Citation": "Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012;61(11):2937\u201347.", "ArticleIdList": ["PMC3478547", "22688339"]}, {"Citation": "Acosta JB, del Barco DG, Vera DC, et al. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J. 2008;5(4):530\u20139.", "ArticleIdList": ["PMC7951400", "19006574"]}, {"Citation": "Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127(3):514\u201325.", "ArticleIdList": ["17299434"]}, {"Citation": "Dangwal S, Stratmann B, Bang C, et al. Impairment of wound healing in patients with type 2 diabetes mellitus influences circulating microRNA patterns via inflammatory cytokines. Arterioscler Thromb Vasc Biol. 2015;35(6):1480\u20138.", "ArticleIdList": ["25814674"]}, {"Citation": "Houreld NN, Sekhejane PR, Abrahamse H. Irradiation at 830 nm stimulates nitric oxide production and inhibits pro-inflammatory cytokines in diabetic wounded fibroblast cells. Lasers Surg Med. 2010;42(6):494\u2013502.", "ArticleIdList": ["20662026"]}, {"Citation": "Gautam MK, Gangwar M, Singh SK, Goel RK. Effects of Azardirachta indica on vascular endothelial growth factor and cytokines in diabetic deep wound. Planta Med. 2015;81(9):713\u201321.", "ArticleIdList": ["26069952"]}, {"Citation": "Pecorelli A, Bocci V, Acquaviva A, et al. NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol Appl Pharmacol. 2013;267(1):30\u201340.", "ArticleIdList": ["23253326"]}, {"Citation": "Re L, Mart\u00ednez-S\u00e1nchez G, Bordicchia M, et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur J Pharmacol. 2014;742:158\u201362.", "ArticleIdList": ["25218903"]}, {"Citation": "Vairaktaris E, Goutzanis L, Nkenke E, et al. Diabetes does not influence oral oncogenesis through fibroblast growth factor receptors. In vivo. 2007;21(4):623\u20138.", "ArticleIdList": ["17708356"]}, {"Citation": "Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen. 2006;14(5):558\u201365.", "ArticleIdList": ["17014667"]}, {"Citation": "Dekker Nitert M, Barrett HL, Kubala MH, et al. Increased placental expression of fibroblast growth factor 21 in gestational diabetes mellitus. J Clin Endocrinol Metab. 2014;99(4):591\u20138.", "ArticleIdList": ["24432989"]}, {"Citation": "Piya MK, Harte AL, Chittari MV, Tripathi G, Kumar S, McTernan PG. FGF21 action on human adipose tissue compromised by reduced \u03b2Klotho and FGFR1 expression in type 2 diabetes mellitus. Endocrine Abstracts. 2013;31:179."}, {"Citation": "Kaftan H, Reuther L, Miehe B, Hosemann W, Beule A. Inhibition of fibroblast growth factor receptor 1: influence on tympanic membrane wound healing in rats. Eur Arch Otorhinolaryngol. 2012;269(1):87\u201392.", "ArticleIdList": ["21590482"]}, {"Citation": "Zhang J, Guan M, Xie C, Luo X, Zhang Q, Xue Y. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxid Med Cell Longev 2014. 2014:273475. doi: 10.1155/2014/273475.", "ArticleIdList": ["PMC4096389", "25089169"]}, {"Citation": "Soares CD, Morais TML, Ara\u00fajo RMFG, et al. Effects of subcutaneous injection of ozone during wound healing in rats. Growth Factors. 2019;37(1-2):95\u2013103.", "ArticleIdList": ["31339390"]}, {"Citation": "Vinnik IuS, Salmina AB, Tepliakova OV, et al. Dynamics of local expression of connexin-43 and basic fibroblast growth factor receptors in patients with skin and soft-tissue infections against the background of diabetes mellitus type II. Vestn Khir Im I I Grek. 2014;173(4):47\u201352.", "ArticleIdList": ["25552106"]}, {"Citation": "Bocci VA. Scientific and ozone therapy. State of the art. Arch Med Res. 2006;37(4):425\u201335.", "ArticleIdList": ["16624639"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "15"}, {"Year": "2021", "Month": "10", "Day": "1"}, {"Year": "2022", "Month": "5", "Day": "12", "Hour": "6", "Minute": "13"}, {"Year": "2022", "Month": "5", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["35546010", "PMC9171882", "10.23750/abm.v93i2.12291"]}}], "PubmedBookArticle": []}